Methods for Preclinical Assessment of the Efficacy of Anticancer Medicines <i>in vivo</i> (Review)
INTRODUCTION. The main risk to the clinical translatability of preclinical results for anticancer medicinal products is posed by the difficulty of simulating clinical conditions in an experimental model. With only 5% of product candidates proving clinically effective, the search for new approaches t...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Russo |
| Veröffentlicht: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
2025-07-01
|
| Schriftenreihe: | Регуляторные исследования и экспертиза лекарственных средств |
| Schlagworte: | |
| Online-Zugang: | https://www.vedomostincesmp.ru/jour/article/view/655 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
